Back

Ensuring access to critical drugs: harnessing policy, technology, and advocacy

14 April 2026 (14:00 - 14:15)
Organised by: Logo
Congress Presentation Part of: Critical medicines, critical times: addressing drug availability for arrhythmia patients topic type Antiarrhythmic Drug Treatment EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Lukasz Szumowski

National Institute of Cardiology, Warsaw (Poland)

3 More presentations in this session

Presentation thumbnail
The European Medicines Agency's list of critical medicines: policies and impact on cardiovascular drug availability
Ms M. Ronconi (BE)
Video
Presentation thumbnail
Mapping the crisis: insights from the EHRA survey on anti-arrhythmic drug availability
Doctor P. Postema (Amsterdam, NL)
Video
Presentation thumbnail
Fostering innovation: advancing research and development of next-generation anti-arrhythmic drugs
Associate Professor C. Remme (Amsterdam, NL)
Video

Access the full session

Session thumbnail
Critical medicines, critical times: addressing drug availability for arrhythmia patients topic type
Video

The Event

Event poster

EHRA 2026

14 April 2026 14:00 CET
You may be interested in
thumbnail
Congress Session
New drugs in preventive cardiology: precision prevention or for all?
24 April 2026
thumbnail
Congress Presentation
What is sustainability from a physician’s perspective?
16 April 2023
thumbnail
Congress Presentation
EHRA activities update
8 April 2024
thumbnail
Congress Presentation
Practical guide to antiarrhythmic drug therapy
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources